Laila Ali is the spokeswoman of a campaign for Astellas Pharma's bladder control drug Myrbetriq in a campaign that will run during ABC's "Dancing with the Stars." This is the second year Astellas has promoted the drug during the show.
Interpublic Group CEO Michael Roth has reportedly discussed who could succeed him when he retires, and possible candidates are Philippe Krakowsky, IPG chief strategy and talent officer, and Harris Diamond, CEO and chairman of McCann Worldgroup. Roth, who is 72, has led the agency since 2005.
A planned initial public offering of 3.3 million shares has been priced by Ra Medical Systems at $14 to $16 per share in hopes of raising $50 million, according to a regulatory filing. The Carlsbad, Calif.-based company markets the DABRA excimer laser-based tool for treatment of dermatological and vascular diseases.
A round of Series A financing has brought in $22.5 million for Boston-based Miach Orthopaedics, which makes bioengineered implants for use in surgical connective tissue repair. The proceeds will be used to advance the company's manufacturing capabilities, as well as for continued clinical trials of its first product in the US.
Switzerland-based startup Luciole Medical has raised $5.5 million in proceeds from a round of Series A financing, which it will use to support the commercialization of its monitoring probe for minimally invasive measurement of cerebral blood oxygen levels in intensive care patients. The company will also use the money for continued development of a noninvasive patch for measuring cerebral blood flow and oxygen saturation during surgery.
Vygon, a French manufacturer of single-use medical devices, has paid an undisclosed amount for a 20% stake in Canadian startup OxyNov, which makes oxygen therapy and respiratory support devices, including the FreeO2 device for automatic and continuous optimization of oxygen flow. OxyNov has also reached a deal with Vygon for the distribution of the device.
Drew Davies, former executive vice president and chief financial officer at Extreme Networks, has been tapped to hold those roles at Natus Medical beginning Oct. 1. Sharon Villaverde, Natus' interim chief financial officer, will continue serving as vice president of finance.
AdvaMed lauded the FDA's proposed list of ways combination products can meet good manufacturing practice standards, although it urged the agency to highlight combination product types and manufacturing processes for which good manufacturing practices differ from standard practices. AdvaMed also called for more details on streamlined or alternative compliance with good manufacturing practices requirements.